Study to Evaluate Hydrochlorothiazide in ADPKD Patients to Enhance Tolvaptan Efficacy
A clinical trial is currently being conducted by the University Medical Center Groningen to evaluate the co-administration of hydrochlorothiazide with tolvaptan in approximately 300 patients diagnosed with autosomal dominant polycystic kidney disease (ADPKD).